Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, discusses three anti-viral medicines currently being tested in clinical trials to treat COVID-19.
Read: Could a Daily Pill Become the Biggest Catalyst to Finally Ending the Pandemic?
